Valiant Laboratories Limited IPO

Mainboard

Commodity Chemicals

Listed On: Oct 6, 2023 at ₹ 162.15(NSE)

₹ 14700 /105 Shares

Check Allotment

Price Summary

Last Closing

120.40 (-14%)

52 Week High

214.95

52 Week Low

100.20

Last Update

19-Sep-2024 3:30 PM

Valiant Laboratories Limited IPO Details

27 Sep, 2023

Open Date

03 Oct, 2023

Close Date

04 Oct, 2023

Allotment Date

06 Oct, 2023

Listing Date

Issue Price

₹133-140 per equity share

Face Value

₹10 Per Equity Share

Listing at Group

BSE, NSE

Registrar

Link Intime India Private Ltd

List Price

162.15(NSE)

Listing Date

2023-10-06

Market Lot

Retail: 105 Shares (₹14,700/-)
S-HNI: 1,470 Shares (₹2,05,800/-)
B-HNI: 7,245 Shares (₹10,14,300/-)

Lead Manager

Unistone Capital Private Limited

Issue Size

11,556,000 shares (aggregating up to ₹152 Cr)
#Fresh Issue: 11,556,000 shares (aggregating up to ₹152 Cr)

Retail Portion

35% (Number of Retail Applications: 36,300 Approx),
(Number of S-HNI Applications : 370 Approx),
(Number of B-HNI Applications : 741 Approx)

Subscription

29.75 times

IPO Docs

DRHP RHP ANCHOR

Valiant Laboratories Limited IPO Subscription Details

As on	QIB	NII bNII sNII	Retail	Total
Shares Offered / Reserved	2,178,030	1,633,500 1,088,999 544,501	3,811,500	7,623,030
Day 1 - 27-09-23 05:00 PM	0.00 x	0.10 0.xx x 0.xx x	0.62 x	0.33 x
Day 2 - 28-09-23 05:00 PM	0.05 x	0.29 0.xx x 0.xx x	1.29 x	0.72 x
Day 3 - 29-09-23 05:00 PM	1.04 x	1.52 6.09 x 3.35 x	3.14 x	2.19 x
Day 4 - 03-10-23 05:00 PM	20.83 x	73.63 78.64 x 63.62 x	16.05 x	29.75 x

Total No. of Applications: 675,925 (Approx)

Valiant Laboratories Limited Valuations

Earnings Per Share (EPS)

₹8.91/-

P/E Ratio

15.71

RoNW

28.86%

Net Asset Value (NAV) - As on 31.03.22

₹N/A

Valiant Laboratories Limited Company Financials All values are in ₹ Cr.

	31-Mar-23	31-Mar-22	31-Mar-21
Assets	212.76	181.81	106.31
Revenue	338.77	293.47	183.78
Profit After Tax	29.00	27.50	30.59

About The Company

Valiant Laboratories Limited is a pharmaceutical ingredient manufacturing company in India having focuses on manufacturing Paracetamol.

The company's manufacturing unit is located in Palghar, Maharashtra, spread across 2,000 sq. mts. of land with an aggregate annual total installed capacity of 9,000 MT per annum. Valiant Laboratories also has an R&D Facility, equipped with an analytical laboratory and infrastructure for developmental activities in existing products.

For the Fiscal 2023, Fiscal 2022 and Fiscal 2021, Valiant Laboratories revenue from operations was Rs. 3,339.10 million, Rs. 2,915.23 million and Rs. 1,823.69 million, respectively.

Valiant Laboratories Limited imports Para Amino Phenol, being the raw material for the manufacture of Paracetamol from China and Cambodia.

As of April 30, 2023, Valiant Laboratories has 86 employees.

Valiant Laboratories Limited - Promoter(s)

Pre Issue Share Holding: 100%

Post Issue Share Holding: 74.94%

Company Promoter(s)

Shantilal Shivji Vora
Dhanvallabh Ventures LLP (DVL)

Valiant Laboratories Limited IPO - Issue Objectives

Investment in its wholly-owned subsidiary, Valiant Advanced Sciences Private Limited (VASPL) for part-financing its capital expenditure requirements in relation to the setting up of a manufacturing facility for specialty chemicals at Saykha Industrial Area, Bharuch, Bharuch, Gujarat (Proposed Facility).
Investment in VASPL for funding its working capital requirements.
General corporate purposes.

Valiant Laboratories Limited IPO - Anchor Investors

Valiant Laboratories raises Rs 45.74 crore via anchor book ahead of IPO.

Leading Light Fund VCC - The Triumph Fund is the largest investor among four anchor investors, buying 14.81 lakh shares worth Rs 20.73 crore.

Saint Capital Fund and Astorne Captal VCC - Arven together invested Rs 20 crore for 7.14 lakh shares each, while Negen Undiscovered Value Fund is the fourth participant, buying 3.57 lakh shares worth Rs 5 crore.

Valiant Laboratories Limited IPO - FAQs

Ans. Valiant Laboratories Limited IPO is a Mainboard IPO. The issue is priced at ₹133-140 per equity share. The minimum order quantity is 105 Shares. The IPO opens on Sep 27, 2023, and closes on Oct 3, 2023. Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

Ans. The Valiant Laboratories Limited IPO opens on Sep 27, 2023 and closes on Oct 3, 2023.

Ans. The size of Valiant Laboratories Limited IPO is 11,556,000 shares (aggregating up to ₹152 Cr) #Fresh Issue: 11,556,000 shares (aggregating up to ₹152 Cr).

Ans. The IPO price band is set between ₹133-140 per equity share.

Ans. To apply for Valiant Laboratories Limited IPO IPO, follow the steps given below:

- Open the IPO Ji App or Website
- Find Valiant Laboratories Limited IPO in the List of IPOs
- Press "Apply" Button
- Select Your Demat Account
- Select Your Shares Quantity and Submit
- Track Your IPO Status

Ans. The share allotment date of Valiant Laboratories Limited IPO is Oct 4, 2023.

Ans. The Valiant Laboratories Limited IPO will be listed on Oct 6, 2023.

Ans. Follow the steps to check the allotment status for Valiant Laboratories Limited IPO here.